Monopar Therapeutics Statistics
Total Valuation
MNPR has a market cap or net worth of $11.86 million. The enterprise value is $3.07 million.
| Market Cap | 11.86M |
| Enterprise Value | 3.07M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, before market open.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MNPR has 17.57 million shares outstanding. The number of shares has increased by 21.93% in one year.
| Shares Outstanding | 17.57M |
| Shares Change (YoY) | +21.93% |
| Shares Change (QoQ) | +9.15% |
| Owned by Insiders (%) | 53.61% |
| Owned by Institutions (%) | 2.26% |
| Float | 8.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.59 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.21, with zero debt.
| Current Ratio | 6.21 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -110.60% and return on invested capital (ROIC) is -107.39%.
| Return on Equity (ROE) | -110.60% |
| Return on Assets (ROA) | -86.50% |
| Return on Capital (ROIC) | -107.39% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$760,887 |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.08% in the last 52 weeks. The beta is 1.18, so MNPR's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -18.08% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 0.58 |
| Relative Strength Index (RSI) | 42.65 |
| Average Volume (20 Days) | 69,720 |
Short Selling Information
The latest short interest is 82,803, so 0.47% of the outstanding shares have been sold short.
| Short Interest | 82,803 |
| Short Previous Month | 86,722 |
| Short % of Shares Out | 0.47% |
| Short % of Float | 1.02% |
| Short Ratio (days to cover) | 0.40 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.03M |
| Pretax Income | -7.61M |
| Net Income | -7.61M |
| EBITDA | -7.61M |
| EBIT | -7.61M |
| Earnings Per Share (EPS) | -$0.52 |
Balance Sheet
The company has $8.79 million in cash and no debt, giving a net cash position of $8.79 million or $0.50 per share.
| Cash & Cash Equivalents | 8.79M |
| Total Debt | n/a |
| Net Cash | 8.79M |
| Net Cash Per Share | $0.50 |
| Equity (Book Value) | 7.48M |
| Book Value Per Share | 0.43 |
| Working Capital | 7.48M |
Cash Flow
| Operating Cash Flow | -7.24M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.24M |
| FCF Per Share | -$0.45 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MNPR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.93% |
| Shareholder Yield | -21.93% |
| Earnings Yield | -64.16% |
| FCF Yield | -61.08% |
Analyst Forecast
The average price target for MNPR is $2.00, which is 196.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.00 |
| Price Target Difference | 196.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |